• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

足细胞糖皮质激素受体在糖尿病肾小球内皮细胞稳态中起关键作用。

Podocyte Glucocorticoid Receptors Are Essential for Glomerular Endothelial Cell Homeostasis in Diabetes Mellitus.

机构信息

Department of Pediatrics Yale University School of Medicine New Haven CT.

Vascular Biology and Therapeutics Program Yale University School of Medicine New Haven CT.

出版信息

J Am Heart Assoc. 2021 Aug 3;10(15):e019437. doi: 10.1161/JAHA.120.019437. Epub 2021 Jul 26.

DOI:10.1161/JAHA.120.019437
PMID:34308664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8475689/
Abstract

Background Proteinuria and glomerular segmental fibrosis are inevitable complications of diabetic nephropathy though their mechanisms are poorly understood. Understanding the clinical characteristics and pathogenesis of proteinuria and glomerular segmental fibrosis in diabetic nephropathy is, therefore, urgently needed for patient management of this severe disease. Methods and Results Diabetes mellitus was induced in podocyte-specific glucocorticoid receptor knockout (GR) mice and control littermates by administration of streptozotocin. Primary podocytes were isolated and subjected to analysis of Wnt signaling and fatty acid metabolism. Conditioned media from primary podocytes was transferred to glomerular endothelial cells. Histologic analysis of kidneys from diabetic GR mice showed worsened fibrosis, increased collagen deposition, and glomerulomegaly indicating severe glomerular fibrosis. Higher expression of transforming growth factor-βR1 and β-catenin and suppressed expression of carnitine palmitoyltransferase 1A in nephrin-positive cells were found in the kidneys of diabetic GR mice. Podocytes isolated from diabetic GR mice demonstrated significantly higher profibrotic gene expression and suppressed fatty acid oxidation compared with controls. Administration of a Wnt inhibitor significantly improved the fibrotic features in GR mice. The glomerular endothelium of diabetic GR mice demonstrated the features of endothelial-to-mesenchymal transition. Moreover, endothelial cells treated with conditioned media from podocytes lacking GR showed increased expression of α-smooth muscle actin, transforming growth factor-βR1 and β-catenin levels. Conclusions These data demonstrate that loss of podocyte GR leads to upregulation of Wnt signaling and disruption in fatty acid metabolism. Podocyte-endothelial cell crosstalk, mediated through GR, is important for glomerular homeostasis, and its disruption likely contributes to diabetic nephropathy.

摘要

背景

蛋白尿和肾小球节段性纤维化是糖尿病肾病不可避免的并发症,但其机制尚不清楚。因此,了解糖尿病肾病中蛋白尿和肾小球节段性纤维化的临床特征和发病机制,对于这种严重疾病患者的管理是迫切需要的。

方法和结果

通过给予链脲佐菌素诱导足细胞特异性糖皮质激素受体敲除(GR)小鼠和对照同窝仔鼠糖尿病。分离原代足细胞并进行 Wnt 信号和脂肪酸代谢分析。将原代足细胞的条件培养基转染至肾小球内皮细胞。糖尿病 GR 小鼠肾脏的组织学分析显示纤维化加重、胶原沉积增加和肾小球肿大,表明严重的肾小球纤维化。糖尿病 GR 小鼠肾脏中肾小球内足突细胞中转化生长因子-βR1 和 β-catenin 表达增加,肉毒碱棕榈酰转移酶 1A 表达受抑制。从糖尿病 GR 小鼠分离的足细胞表现出明显更高的致纤维化基因表达和抑制的脂肪酸氧化。Wnt 抑制剂的给药显著改善了 GR 小鼠的纤维化特征。糖尿病 GR 小鼠的肾小球内皮细胞表现出内皮-间充质转化的特征。此外,用缺乏 GR 的足细胞的条件培养基处理的内皮细胞显示出α-平滑肌肌动蛋白、转化生长因子-βR1 和 β-catenin 水平的表达增加。

结论

这些数据表明,足细胞 GR 的缺失导致 Wnt 信号的上调和脂肪酸代谢的破坏。足细胞-内皮细胞的串扰,通过 GR 介导,对肾小球稳态很重要,其破坏可能导致糖尿病肾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a47/8475689/79e51082926d/JAH3-10-e019437-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a47/8475689/fc69d9235564/JAH3-10-e019437-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a47/8475689/c80d35124070/JAH3-10-e019437-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a47/8475689/1beab2c0bcf9/JAH3-10-e019437-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a47/8475689/b38fc34b26d4/JAH3-10-e019437-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a47/8475689/028ff248da7d/JAH3-10-e019437-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a47/8475689/ffc000b38568/JAH3-10-e019437-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a47/8475689/79e51082926d/JAH3-10-e019437-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a47/8475689/fc69d9235564/JAH3-10-e019437-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a47/8475689/c80d35124070/JAH3-10-e019437-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a47/8475689/1beab2c0bcf9/JAH3-10-e019437-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a47/8475689/b38fc34b26d4/JAH3-10-e019437-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a47/8475689/028ff248da7d/JAH3-10-e019437-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a47/8475689/ffc000b38568/JAH3-10-e019437-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a47/8475689/79e51082926d/JAH3-10-e019437-g004.jpg

相似文献

1
Podocyte Glucocorticoid Receptors Are Essential for Glomerular Endothelial Cell Homeostasis in Diabetes Mellitus.足细胞糖皮质激素受体在糖尿病肾小球内皮细胞稳态中起关键作用。
J Am Heart Assoc. 2021 Aug 3;10(15):e019437. doi: 10.1161/JAHA.120.019437. Epub 2021 Jul 26.
2
Loss of endothelial glucocorticoid receptor accelerates diabetic nephropathy.内皮糖皮质激素受体缺失加速糖尿病肾病。
Nat Commun. 2021 Apr 22;12(1):2368. doi: 10.1038/s41467-021-22617-y.
3
Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.足细胞特异性Nox4缺失在糖尿病肾病小鼠模型中提供肾脏保护作用。
Diabetologia. 2016 Feb;59(2):379-89. doi: 10.1007/s00125-015-3796-0. Epub 2015 Oct 28.
4
Hedgehog Interacting Protein Promotes Fibrosis and Apoptosis in Glomerular Endothelial Cells in Murine Diabetes.刺猬相互作用蛋白促进糖尿病小鼠肾小球内皮细胞的纤维化和细胞凋亡。
Sci Rep. 2018 Apr 13;8(1):5958. doi: 10.1038/s41598-018-24220-6.
5
Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.间充质干细胞改善 1 型糖尿病肾病大鼠模型的足细胞损伤和蛋白尿。
Biol Blood Marrow Transplant. 2013 Apr;19(4):538-46. doi: 10.1016/j.bbmt.2013.01.001. Epub 2013 Jan 4.
6
Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.足细胞特异性趋化因子(C-C基序)受体2的过表达介导小鼠糖尿病肾损伤。
Kidney Int. 2017 Mar;91(3):671-682. doi: 10.1016/j.kint.2016.09.042. Epub 2016 Dec 1.
7
LncRNA MALAT1 is dysregulated in diabetic nephropathy and involved in high glucose-induced podocyte injury via its interplay with β-catenin.长链非编码 RNA MALAT1 在糖尿病肾病中失调,并通过与 β-连环蛋白相互作用参与高糖诱导的足细胞损伤。
J Cell Mol Med. 2017 Nov;21(11):2732-2747. doi: 10.1111/jcmm.13189. Epub 2017 Apr 26.
8
eNOS deficiency predisposes podocytes to injury in diabetes.内皮型一氧化氮合酶缺乏使足细胞易受糖尿病损伤。
J Am Soc Nephrol. 2012 Nov;23(11):1810-23. doi: 10.1681/ASN.2011121170. Epub 2012 Sep 20.
9
Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease.四半LIM结构域蛋白2是糖尿病肾病中Wnt信号通路的一种共激活因子。
J Am Soc Nephrol. 2015 Dec;26(12):3072-84. doi: 10.1681/ASN.2014100989. Epub 2015 Apr 8.
10
Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.CTGF抗体通过降低肾小球β-连环蛋白表达和足细胞上皮-间质转化对小鼠糖尿病肾病的保护作用
J Cell Biochem. 2017 Nov;118(11):3706-3712. doi: 10.1002/jcb.26017. Epub 2017 May 16.

引用本文的文献

1
Bioengineered platelet nanoplatform enables renal-targeted dexamethasone delivery for chronic nephritis therapy with dual anti-inflammatory/anti-fibrotic effects and minimized systemic toxicity.生物工程血小板纳米平台实现肾靶向地塞米松递送,用于慢性肾炎治疗,具有双重抗炎/抗纤维化作用,并将全身毒性降至最低。
Bioact Mater. 2025 Jun 7;52:213-227. doi: 10.1016/j.bioactmat.2025.06.002. eCollection 2025 Oct.
2
Metabolic reprogramming by endothelial ANGPTL4 depletion protects against diabetic kidney disease.内皮细胞血管生成素样蛋白4缺失引起的代谢重编程可预防糖尿病肾病。
bioRxiv. 2025 May 12:2025.05.08.652142. doi: 10.1101/2025.05.08.652142.
3

本文引用的文献

1
Loss of endothelial glucocorticoid receptor accelerates diabetic nephropathy.内皮糖皮质激素受体缺失加速糖尿病肾病。
Nat Commun. 2021 Apr 22;12(1):2368. doi: 10.1038/s41467-021-22617-y.
2
Loss of Mitochondrial Control Impacts Renal Health.线粒体控制功能丧失影响肾脏健康。
Front Pharmacol. 2020 Dec 9;11:543973. doi: 10.3389/fphar.2020.543973. eCollection 2020.
3
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.非奈利酮对 2 型糖尿病患者慢性肾脏病结局的影响。
Editorial: Diabetic kidney disease: routes to drug development, pharmacology and underlying molecular mechanisms, volume II.
社论:糖尿病肾病:药物研发途径、药理学及潜在分子机制,第二卷
Front Pharmacol. 2025 Apr 25;16:1609100. doi: 10.3389/fphar.2025.1609100. eCollection 2025.
4
The molecular determinants regulating redox signaling in diabetic endothelial cells.调节糖尿病内皮细胞氧化还原信号的分子决定因素。
Front Pharmacol. 2025 Apr 1;16:1563047. doi: 10.3389/fphar.2025.1563047. eCollection 2025.
5
Cellular cross-talk drives mesenchymal transdifferentiation in diabetic kidney disease.细胞间相互作用驱动糖尿病肾病中的间充质转分化。
Front Med (Lausanne). 2025 Jan 7;11:1499473. doi: 10.3389/fmed.2024.1499473. eCollection 2024.
6
FGF21 ameliorates diabetic nephropathy through CDK1-dependently regulating the cell cycle.成纤维细胞生长因子21通过依赖细胞周期蛋白依赖性激酶1调控细胞周期来改善糖尿病肾病。
Front Pharmacol. 2025 Jan 3;15:1500458. doi: 10.3389/fphar.2024.1500458. eCollection 2024.
7
Renal Angptl4 is a key fibrogenic molecule in progressive diabetic kidney disease.肾血管生成素样蛋白4是进行性糖尿病肾病中的关键促纤维化分子。
Sci Adv. 2024 Dec 6;10(49):eadn6068. doi: 10.1126/sciadv.adn6068. Epub 2024 Dec 4.
8
HOXD10 attenuates renal fibrosis by inhibiting NOX4-induced ferroptosis.HOXD10 通过抑制 NOX4 诱导的铁死亡来减轻肾纤维化。
Cell Death Dis. 2024 Jun 6;15(6):398. doi: 10.1038/s41419-024-06780-w.
9
Crosstalk among podocytes, glomerular endothelial cells and mesangial cells in diabetic kidney disease: an updated review.糖尿病肾病中足细胞、肾小球内皮细胞和系膜细胞之间的相互作用:最新综述
Cell Commun Signal. 2024 Feb 19;22(1):136. doi: 10.1186/s12964-024-01502-3.
10
Editorial: Current understanding of complications associated with diabetes.社论:对糖尿病相关并发症的当前认识
Front Clin Diabetes Healthc. 2023 Dec 6;4:1338656. doi: 10.3389/fcdhc.2023.1338656. eCollection 2023.
N Engl J Med. 2020 Dec 3;383(23):2219-2229. doi: 10.1056/NEJMoa2025845. Epub 2020 Oct 23.
4
Nuclear receptors in podocyte biology and glomerular disease.足细胞生物学和肾小球疾病中的核受体。
Nat Rev Nephrol. 2021 Mar;17(3):185-204. doi: 10.1038/s41581-020-00339-6. Epub 2020 Sep 17.
5
Metabolic reprogramming by N-acetyl-seryl-aspartyl-lysyl-proline protects against diabetic kidney disease.N-乙酰丝氨酰-天冬氨酰-赖氨酰-脯氨酸介导的代谢重编程对糖尿病肾病具有保护作用。
Br J Pharmacol. 2020 Aug;177(16):3691-3711. doi: 10.1111/bph.15087. Epub 2020 Jun 22.
6
Renal protective effects of empagliflozin via inhibition of EMT and aberrant glycolysis in proximal tubules.恩格列净通过抑制近端肾小管 EMT 和异常糖酵解发挥肾脏保护作用。
JCI Insight. 2020 Mar 26;5(6):129034. doi: 10.1172/jci.insight.129034.
7
Inhibition of Angiotensin-Converting Enzyme Ameliorates Renal Fibrosis by Mitigating DPP-4 Level and Restoring Antifibrotic MicroRNAs.血管紧张素转化酶抑制剂通过减轻 DPP-4 水平和恢复抗纤维化 microRNAs 来减轻肾脏纤维化。
Genes (Basel). 2020 Feb 18;11(2):211. doi: 10.3390/genes11020211.
8
Endothelial cell-glucocorticoid receptor interactions and regulation of Wnt signaling.内皮细胞-糖皮质激素受体相互作用及 Wnt 信号的调节。
JCI Insight. 2020 Feb 13;5(3):131384. doi: 10.1172/jci.insight.131384.
9
Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial.达格列净和预防慢性肾脏病不良结局(DAPA-CKD)随机对照试验的原理和方案。
Nephrol Dial Transplant. 2020 Feb 1;35(2):274-282. doi: 10.1093/ndt/gfz290.
10
microRNA Crosstalk Influences Epithelial-to-Mesenchymal, Endothelial-to-Mesenchymal, and Macrophage-to-Mesenchymal Transitions in the Kidney.微小RNA相互作用影响肾脏中的上皮-间充质、内皮-间充质和巨噬细胞-间充质转化。
Front Pharmacol. 2019 Aug 16;10:904. doi: 10.3389/fphar.2019.00904. eCollection 2019.